First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer

In several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [(68)Ga]-radiolabeled inhibitors of FAP also in cervical cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wegen, Simone, Roth, Katrin Sabine, Weindler, Jasmin, Claus, Karina, Linde, Philipp, Trommer, Maike, Akuamoa-Boateng, Dennis, van Heek, Lutz, Baues, Christian, Schömig-Markiefka, Birgid, Schomäcker, Klaus, Fischer, Thomas, Drzezga, Alexander, Kobe, Carsten, Köhler, Christhardt, Marnitz, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835656/
https://www.ncbi.nlm.nih.gov/pubmed/36607364
http://dx.doi.org/10.1097/RLU.0000000000004505
Descripción
Sumario:In several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [(68)Ga]-radiolabeled inhibitors of FAP also in cervical cancer (CC). Our study aims to explore the accuracy of [(68)Ga]Ga–fibroblast activation protein inhibitor (FAPI)-46 PET/CT and [(18)F]F-FDG PET/CT compared with histopathological results of surgical lymph node (LN) staging before primary chemoradiation. METHODS: Seven consecutive women with treatment-naive and biopsy-proven locally advanced CC underwent both whole-body [(68)Ga]Ga-FAPI-46- and [(18)F]F-FDG PET/CT, for imaging nodal staging before systematic laparoscopic lymphadenectomy of the pelvic and para-aortic region. Location and number of suspicious LNs in PET imaging were recorded and compared with the results of histopathological analysis, including immunohistochemical staining for FAP. RESULTS: All 7 patients had focal uptake above background in their tumor lesions in [(68)Ga]Ga-FAPI-46 PET/CT. [(68)Ga]Ga-FAPI-46 PET/CT showed a higher tumor-to-background ratio (TBR) in primary tumor as well as in LN metastasis. Median TBR(max) values using liver were 32.02 and 5.15 for [(68)Ga]Ga-FAPI-46 PET/CT and [(18)F]F-FDG PET/CT, respectively. Median TBR(max) using blood pool was 18.45 versus 6.85 for [(68)Ga]Ga-FAPI-46 PET/CT and [(18)F]F-FDG PET/CT, respectively. Higher TBR also applies for nodal metastasis: TBR(max) was 14.55 versus 1.39 (liver) and 7.97 versus 1.8 (blood pool) for [(68)Ga]Ga-FAPI-46 PET/CT and [(18)F]F-FDG PET/CT, respectively. Overall, [(68)Ga]Ga-FAPI-46 PET/CT detected more lesions compared with [(18)F]F-FDG PET/CT. Following surgical staging, a total of 5 metastatic LNs could be pathologically confirmed, of which 2 and 4 were positive by [(18)F]F-FDG PET/CT and [(68)Ga]Ga-FAPI-46 PET/CT, respectively. CONCLUSION: [(68)Ga]Ga-FAPI-46 PET/CT seems useful to improve detection of nodal metastasis in patients with CCs. Future studies should aim to compare [(68)Ga]Ga-FAPI-46 PET/CT to surgical staging of pelvic and para-aortic LNs in patients with locally advanced CC.

Ejemplares similares